Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non‐epigenetic manners

[1]  F. Zoulim,et al.  Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector. , 2017, Antiviral research.

[2]  Zhuanchang Wu,et al.  NgAgo-gDNA system efficiently suppresses hepatitis B virus replication through accelerating decay of pregenomic RNA. , 2017, Antiviral research.

[3]  Sumedha Bagga,et al.  Hepatitis B virus molecular biology and pathogenesis. , 2016, Hepatoma research.

[4]  K. Chayama,et al.  Early events in hepatitis B virus infection: From the cell surface to the nucleus , 2016, Journal of gastroenterology and hepatology.

[5]  J. Davie,et al.  Histone H3K4 trimethylation: dynamic interplay with pre-mRNA splicing. , 2016, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[6]  Yan Wang,et al.  Proliferation and osteo/odontogenic differentiation of stem cells from apical papilla regulated by Zinc fingers and homeoboxes 2: An in vitro study. , 2016, Biochemical and biophysical research communications.

[7]  P. Karayiannis,et al.  The Epigenetic Control of Hepatitis B Virus Modulates the Outcome of Infection , 2016, Front. Microbiol..

[8]  Meghan M. Holdorf,et al.  Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation , 2015, Proceedings of the National Academy of Sciences.

[9]  M. Nassal.  HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B , 2015, Gut.

[10]  Y. Liu,et al.  Zinc fingers and homeoboxes family in human diseases , 2015, Cancer Gene Therapy.

[11]  Xuetian Yue,et al.  ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA , 2014, Oncotarget.

[12]  A. Lok,et al.  Hepatitis B virus infection , 2014, The Lancet.

[13]  P. Liu,et al.  Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma. , 2014, The international journal of biochemistry & cell biology.

[14]  Yueqiu Gao,et al.  Recombinant Covalently Closed Circular Hepatitis B Virus DNA Induces Prolonged Viral Persistence in Immunocompetent Mice , 2014, Journal of Virology.

[15]  Mengji Lu,et al.  Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs , 2013, Front. Genet..

[16]  Wenhui Li,et al.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus , 2012, eLife.

[17]  Y. Gong,et al.  Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E. , 2012, Gastroenterology.

[18]  M. Levrero,et al.  IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. , 2012, The Journal of clinical investigation.

[19]  Xiu-mei Li,et al.  Preparation and identification of 1.3 copies C-type HBV transgenic mice , 2011 .

[20]  U. Protzer,et al.  Control of hepatitis B virus at the level of transcription , 2010, Journal of viral hepatitis.

[21]  M. Levrero,et al.  Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function , 2009, Proceedings of the National Academy of Sciences.

[22]  Q. Lu,et al.  ZHX2 Interacts with Ephrin-B and Regulates Neural Progenitor Maintenance in the Developing Cerebral Cortex , 2009, The Journal of Neuroscience.

[23]  X. Liang,et al.  ZHX2 is a repressor of α-fetoprotein expression in human hepatoma cell lines , 2008, Journal of cellular and molecular medicine.

[24]  Y. Kanwar,et al.  ZHX Proteins Regulate Podocyte Gene Expression during the Development of Nephrotic Syndrome* , 2006, Journal of Biological Chemistry.

[25]  D. Milich,et al.  Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection , 2003, Hepatology.

[26]  Kazuya Yamada,et al.  Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor. , 2003, The Biochemical journal.

[27]  N. Moolla,et al.  Regulatory elements of hepatitis B virus transcription , 2002, Journal of viral hepatitis.

[28]  M. Kew,et al.  The core promoter of hepatitis B virus , 1999, Journal of viral hepatitis.

[29]  M. Manns,et al.  Two control elements in the hepatitis B virus S‐promoter are important for full promoter activity mediated by CCAAT‐binding factor , 1999, Hepatology.

[30]  H. Lee,et al.  Liver-specific Enhancer II Is the Target for the p53-mediated Inhibition of Hepatitis B Viral Gene Expression* , 1998, The Journal of Biological Chemistry.

[31]  A. Ori,et al.  p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53 , 1998, The EMBO journal.

[32]  T. Yen,et al.  Activation of the hepatitis B virus S promoter by transcription factor NF-Y via a CCAAT element. , 1996, Virology.

[33]  W. Rutter,et al.  Transcription of hepatitis B virus by RNA polymerase II , 1983, Molecular and cellular biology.